Clinical Trial Update: Rituximab Vasculitis Maintenance Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for rituximab maintenance in ANCA-associated vasculitis, including microscopic polyangiitis and Wegener granulomatosis, with compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
• Microscopic Polyangiitis
• Wegener Granulomatosis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis | Phase 3 | Status: COMPLETED | Results posted: 2022-03-18